While 18F-choline, 11C-choline, 11C-acetate, and 18F-fluciclovine have all shown promise in prostate cancer imaging, prostate-specific membrane antigen (PSMA) has shown the most promise when combined with MRI. This evidence concerns the gene FOLH1 and prostate carcinoma.